Drug intelligence / Profile preview

Wenshengyang Granules

Development stage: Preclinical
Lead developer: Shanghai University of Traditional Chinese Medicine
Modality: Small Molecules
Administration: Oral

Overview

Wenshengyang Granules is an innovative Traditional Chinese Medicine (TCM) candidate (Class 1.1) developed by the Shanghai University of Traditional Chinese Medicine in collaboration with Chengji (Zhuhai Hengqin) Pharmaceutical Technology. It is formulated as oral granules specifically for the treatment of osteoporosis associated with the Kidney-yang deficiency syndrome. In TCM theory, the kidney is believed to govern bone health, and this formulation aims to restore balance and improve bone mineral density by tonifying Kidney-yang. The project is part of the Shanghai TCM Science and Technology Innovation Project and is currently in the preclinical development phase.

Other names: 温肾阳颗粒Wenshengyang Keli

Beyond the preview

Go deeper on Wenshengyang Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wenshengyang Granules.

Explore the full profile